Rhythm Pharmaceuticals Ownership 2024 | Who Owns Rhythm Pharmaceuticals Now?
Institutional Ownership
51.37%
Insider Ownership
0.57%
Retail Ownership
48.06%
Institutional Holders
92.00
Rhythm Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PRIMECAP MANAGEMENT CO/CA/ | 12.16% | 0.22% | 7,312,391 | -435,200 | -5.62% | 300,246,774 | Jun 30, 2024 |
| BLACKROCK INC. | 11.21% | 0.01% | 6,741,923 | 212,277 | 3.25% | 276,823,359 | Jun 30, 2024 |
| BAKER BROS. ADVISORS LP | 10.64% | 3.36% | 6,398,365 | - | - | 262,716,867 | Jun 30, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | 10.12% | 3.30% | 6,084,412 | 754,000 | 14.15% | 249,825,957 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 8.79% | 0.04% | 5,288,635 | 177,034 | 3.46% | 217,151,353 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 5.73% | 3.36% | 3,446,579 | 178,000 | 5.45% | 141,516,534 | Jun 30, 2024 |
| VANGUARD GROUP INC | 5.59% | 0.00% | 3,360,695 | 56,549 | 1.71% | 137,990,136 | Jun 30, 2024 |
| NEA MANAGEMENT COMPANY, LLC | 4.84% | 8.99% | 2,909,956 | - | - | 119,482,793 | Jun 30, 2024 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 3.94% | 4.55% | 2,371,304 | 181,125 | 8.27% | 97,365,742 | Jun 30, 2024 |
| STATE STREET CORP | 3.33% | 0.00% | 2,003,882 | -1,009,956 | -33.51% | 82,279,395,000 | Jun 30, 2024 |
| FEDERATED HERMES, INC. | 2.76% | 0.16% | 1,660,784 | -313 | -0.02% | 68,191,791,000 | Jun 30, 2024 |
| POLAR CAPITAL HOLDINGS PLC | 2.49% | 0.36% | 1,500,000 | - | - | 61,590,000 | Jun 30, 2024 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 2.13% | 1.58% | 1,280,493 | -242,400 | -15.92% | 52,577,043 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.08% | 0.00% | 1,252,689 | 71,984 | 6.10% | 51,445,353 | Jun 30, 2024 |
| COMMODORE CAPITAL LP | 2.04% | 3.43% | 1,225,000 | 175,000 | 16.67% | 50,298,500 | Jun 30, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1.97% | 0.47% | 1,182,370 | 326,865 | 38.21% | 48,548,112 | Jun 30, 2024 |
| ALKEON CAPITAL MANAGEMENT LLC | 1.66% | 0.07% | 1,000,000 | 1,000,000 | 100.00% | 41,060,000 | Jun 30, 2024 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 1.61% | 0.11% | 967,243 | 236,600 | 32.38% | 39,714,998 | Jun 30, 2024 |
| CHECKPOINT CAPITAL L.P. | 1.53% | 22.82% | 922,100 | 96,600 | 11.70% | 37,861,426 | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 1.33% | 0.04% | 801,796 | -409,883 | -33.83% | 32,921,744 | Jun 30, 2024 |
Rhythm Pharmaceuticals's largest institutional shareholder is PRIMECAP MANAGEMENT CO/CA/, holding 12.16% of the company's total share outstanding, currently valued at $300.25M. The top 10 institutional shareholders own together 76.35% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CHECKPOINT CAPITAL L.P. | 1.53% | 22.82% | 922,100 | 96,600 | 11.70% | 37,861,426 | Jun 30, 2024 |
| NEA MANAGEMENT COMPANY, LLC | 4.84% | 8.99% | 2,909,956 | - | - | 119,482,793 | Jun 30, 2024 |
| OPALEYE MANAGEMENT INC. | 0.86% | 4.83% | 515,000 | - | - | 21,145,900 | Jun 30, 2024 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 3.94% | 4.55% | 2,371,304 | 181,125 | 8.27% | 97,365,742 | Jun 30, 2024 |
| COMMODORE CAPITAL LP | 2.04% | 3.43% | 1,225,000 | 175,000 | 16.67% | 50,298,500 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 5.73% | 3.36% | 3,446,579 | 178,000 | 5.45% | 141,516,534 | Jun 30, 2024 |
| BAKER BROS. ADVISORS LP | 10.64% | 3.36% | 6,398,365 | - | - | 262,716,867 | Jun 30, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | 10.12% | 3.30% | 6,084,412 | 754,000 | 14.15% | 249,825,957 | Jun 30, 2024 |
| NAN FUNG GROUP HOLDINGS LTD | 0.08% | 2.15% | 49,120 | - | - | 2,016,867 | Jun 30, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 0.31% | 1.79% | 184,662 | 886 | 0.48% | 7,582,222 | Jun 30, 2024 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 2.13% | 1.58% | 1,280,493 | -242,400 | -15.92% | 52,577,043 | Jun 30, 2024 |
| GHOST TREE CAPITAL, LLC | 0.20% | 1.51% | 117,388 | -7,612 | -6.09% | 4,819,951 | Jun 30, 2024 |
| SAMSARA BIOCAPITAL, LLC | 0.29% | 1.48% | 172,647 | - | - | 7,088,886 | Jun 30, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | 0.79% | 1.13% | 475,000 | -75,000 | -13.64% | 19,503,500 | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | 1.17% | 0.58% | 704,842 | - | - | 28,940,813 | Jun 30, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1.97% | 0.47% | 1,182,370 | 326,865 | 38.21% | 48,548,112 | Jun 30, 2024 |
| POLAR CAPITAL HOLDINGS PLC | 2.49% | 0.36% | 1,500,000 | - | - | 61,590,000 | Jun 30, 2024 |
| JGP GLOBAL GESTAO DE RECURSOS LTDA. | 0.01% | 0.30% | 5,814 | -100,000 | -94.51% | 238,723 | Jun 30, 2024 |
| RICE HALL JAMES & ASSOCIATES, LLC | 0.15% | 0.23% | 93,081 | 3,355 | 3.74% | 3,821,906 | Jun 30, 2024 |
| PRIMECAP MANAGEMENT CO/CA/ | 12.16% | 0.22% | 7,312,391 | -435,200 | -5.62% | 300,246,774 | Jun 30, 2024 |
The largest Rhythm Pharmaceuticals shareholder by % of total assets is CHECKPOINT CAPITAL L.P.. The company owns 922.10K shares of Rhythm Pharmaceuticals (RYTM), representing 22.82% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ALKEON CAPITAL MANAGEMENT LLC | 1.66% | 0.07% | 1,000,000 | 1,000,000 | 100.00% | 41,060,000 | Jun 30, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | 10.12% | 3.30% | 6,084,412 | 754,000 | 14.15% | 249,825,957 | Jun 30, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1.97% | 0.47% | 1,182,370 | 326,865 | 38.21% | 48,548,112 | Jun 30, 2024 |
| MORGAN STANLEY | 0.79% | 0.00% | 475,651 | 292,781 | 160.10% | 19,530,231 | Jun 30, 2024 |
| CANDRIAM S.C.A. | 0.45% | 0.07% | 271,398 | 271,398 | 100.00% | 11,143,082 | Jun 30, 2024 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 1.61% | 0.11% | 967,243 | 236,600 | 32.38% | 39,714,998 | Jun 30, 2024 |
| NISA INVESTMENT ADVISORS, LLC | 0.62% | 0.10% | 374,347 | 229,056 | 157.65% | 15,370,688 | Jun 30, 2024 |
| BLACKROCK INC. | 11.21% | 0.01% | 6,741,923 | 212,277 | 3.25% | 276,823,359 | Jun 30, 2024 |
| INVESCO LTD. | 0.46% | 0.00% | 276,700 | 188,495 | 213.70% | 11,361,303 | Jun 30, 2024 |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 3.94% | 4.55% | 2,371,304 | 181,125 | 8.27% | 97,365,742 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 5.73% | 3.36% | 3,446,579 | 178,000 | 5.45% | 141,516,534 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 8.79% | 0.04% | 5,288,635 | 177,034 | 3.46% | 217,151,353 | Jun 30, 2024 |
| COMMODORE CAPITAL LP | 2.04% | 3.43% | 1,225,000 | 175,000 | 16.67% | 50,298,500 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 0.28% | 0.11% | 169,000 | 169,000 | 100.00% | 6,939,140 | Jun 30, 2024 |
| NOMURA HOLDINGS INC | 0.26% | 0.01% | 157,300 | 157,300 | 100.00% | 6,458,738 | Jun 30, 2024 |
| ABRDN PLC | 0.19% | 0.01% | 112,804 | 112,804 | 100.00% | 4,631,732 | Jun 30, 2024 |
| HAP TRADING, LLC | 0.18% | 0.04% | 109,800 | 109,800 | 100.00% | 312,930 | Jun 30, 2024 |
| CHECKPOINT CAPITAL L.P. | 1.53% | 22.82% | 922,100 | 96,600 | 11.70% | 37,861,426 | Jun 30, 2024 |
| FIRST TRUST ADVISORS LP | 0.15% | 0.00% | 91,010 | 91,010 | 100.00% | 3,736,870 | Jun 30, 2024 |
| MARSHALL WACE, LLP | 0.18% | 0.01% | 106,809 | 87,059 | 440.81% | 4,385,578 | Jun 30, 2024 |
As of Jun 30 2024, Rhythm Pharmaceuticals's largest institutional buyer is ALKEON CAPITAL MANAGEMENT LLC. The company purchased 1.00M stocks of RYTM, valued at $41.06M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| STATE STREET CORP | 3.33% | 0.00% | 2,003,882 | -1,009,956 | -33.51% | 82,279,395,000 | Jun 30, 2024 |
| PRIMECAP MANAGEMENT CO/CA/ | 12.16% | 0.22% | 7,312,391 | -435,200 | -5.62% | 300,246,774 | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 1.33% | 0.04% | 801,796 | -409,883 | -33.83% | 32,921,744 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 0.08% | 0.03% | 50,000 | -369,300 | -88.08% | 2,053,000 | Jun 30, 2024 |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 2.13% | 1.58% | 1,280,493 | -242,400 | -15.92% | 52,577,043 | Jun 30, 2024 |
| LORD, ABBETT & CO. LLC | 0.17% | 0.01% | 102,591 | -178,566 | -63.51% | 4,213,000 | Jun 30, 2024 |
| CANADA PENSION PLAN INVESTMENT BOARD | 0.69% | 0.02% | 417,000 | -160,000 | -27.73% | 17,122,020 | Jun 30, 2024 |
| RAFFERTY ASSET MANAGEMENT, LLC | 0.12% | 0.01% | 72,562 | -146,095 | -66.81% | 2,979,396 | Jun 30, 2024 |
| VOYA INVESTMENT MANAGEMENT LLC | 0.06% | 0.00% | 37,811 | -131,900 | -77.72% | 1,552,519 | Jun 30, 2024 |
| WOODLINE PARTNERS LP | 0.07% | 0.02% | 44,247 | -127,960 | -74.31% | 1,816,782 | Jun 30, 2024 |
| UBS GROUP AG | 0.11% | 0.00% | 65,942 | -105,623 | -61.56% | 2,707,578 | Jun 30, 2024 |
| JGP GLOBAL GESTAO DE RECURSOS LTDA. | 0.01% | 0.30% | 5,814 | -100,000 | -94.51% | 238,723 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.04% | 0.00% | 26,243 | -82,512 | -75.87% | 1,077,538 | Jun 30, 2024 |
| CORMORANT ASSET MANAGEMENT, LP | 0.79% | 1.13% | 475,000 | -75,000 | -13.64% | 19,503,500 | Jun 30, 2024 |
| BARCLAYS PLC | 0.09% | 0.00% | 53,631 | -73,905 | -57.95% | 2,202,000 | Jun 30, 2024 |
| JEFFERIES FINANCIAL GROUP INC. | - | - | - | -68,566 | -100.00% | - | Jun 30, 2024 |
| ALTIUM CAPITAL MANAGEMENT LP | - | - | - | -57,271 | -100.00% | - | Jun 30, 2024 |
| ASSENAGON ASSET MANAGEMENT S.A. | 0.38% | 0.02% | 229,491 | -56,160 | -19.66% | 9,422,900 | Jun 30, 2024 |
| TORNO CAPITAL, LLC | - | - | - | -55,000 | -100.00% | - | Jun 30, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | 0.01% | 0.00% | 3,543 | -52,466 | -93.67% | 145,476 | Jun 30, 2024 |
As of Jun 30 2024, Rhythm Pharmaceuticals's biggest institutional seller is STATE STREET CORP. The company sold -1.01M shares of RYTM, valued at $82.28B.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ALKEON CAPITAL MANAGEMENT LLC | 1.66% | 0.07% | 1,000,000 | 1,000,000 | 100.00% | 41,060,000 | Jun 30, 2024 |
| CANDRIAM S.C.A. | 0.45% | 0.07% | 271,398 | 271,398 | 100.00% | 11,143,082 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 0.28% | 0.11% | 169,000 | 169,000 | 100.00% | 6,939,140 | Jun 30, 2024 |
| NOMURA HOLDINGS INC | 0.26% | 0.01% | 157,300 | 157,300 | 100.00% | 6,458,738 | Jun 30, 2024 |
| ABRDN PLC | 0.19% | 0.01% | 112,804 | 112,804 | 100.00% | 4,631,732 | Jun 30, 2024 |
| HAP TRADING, LLC | 0.18% | 0.04% | 109,800 | 109,800 | 100.00% | 312,930 | Jun 30, 2024 |
| FIRST TRUST ADVISORS LP | 0.15% | 0.00% | 91,010 | 91,010 | 100.00% | 3,736,870 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | 0.07% | 0.03% | 44,984 | 44,984 | 100.00% | 1,847,043 | Jun 30, 2024 |
| NORGES BANK | 0.07% | 0.00% | 43,238 | 43,238 | 100.00% | 1,775,352 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.05% | 0.00% | 30,391 | 30,391 | 100.00% | 1,245,314 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.05% | 0.01% | 29,454 | 29,454 | 100.00% | 1,209,381 | Jun 30, 2024 |
| GTS SECURITIES LLC | 0.04% | 0.00% | 23,136 | 23,136 | 100.00% | 949,964 | Jun 30, 2024 |
| QUANTINNO CAPITAL MANAGEMENT LP | 0.03% | 0.01% | 18,120 | 18,120 | 100.00% | 744,007 | Jun 30, 2024 |
| EXCHANGE TRADED CONCEPTS, LLC | 0.02% | 0.01% | 11,920 | 11,920 | 100.00% | 489,435 | Jun 30, 2024 |
| PDT PARTNERS, LLC | 0.02% | 0.04% | 11,510 | 11,510 | 100.00% | 472,601 | Jun 30, 2024 |
| KENNEDY CAPITAL MANAGEMENT LLC | 0.02% | 0.01% | 11,154 | 11,154 | 100.00% | 457,983 | Jun 30, 2024 |
| SCHONFELD STRATEGIC ADVISORS LLC | 0.02% | 0.00% | 10,921 | 10,921 | 100.00% | 448,415 | Jun 30, 2024 |
| TOROSO INVESTMENTS, LLC | 0.01% | 0.01% | 9,011 | 9,011 | 100.00% | 369,991 | Jun 30, 2024 |
| ORG PARTNERS LLC | 0.00% | 0.01% | 1,206 | 1,206 | 100.00% | 51,460,000 | Jun 30, 2024 |
| JONES FINANCIAL COMPANIES LLLP | 0.00% | - | 231 | 231 | 100.00% | 9,485 | Jun 30, 2024 |
| MATHER GROUP, LLC. | 0.00% | - | 65 | 65 | 100.00% | 2,816 | Jun 30, 2024 |
| SRS CAPITAL ADVISORS, INC. | 0.00% | 0.00% | 54 | 54 | 100.00% | 2,218 | Jun 30, 2024 |
| SMARTLEAF ASSET MANAGEMENT LLC | - | 0.00% | 13 | 13 | 100.00% | 521 | Jun 30, 2024 |
| CVA FAMILY OFFICE, LLC | - | 0.00% | 12 | 12 | 100.00% | 493 | Jun 30, 2024 |
| INNEALTA CAPITAL, LLC | - | 0.00% | 7 | 7 | 100.00% | 287 | Jun 30, 2024 |
Rhythm Pharmaceuticals's largest new institutional shareholder by number of shares is ALKEON CAPITAL MANAGEMENT LLC, purchased 1.00M shares, valued at $41.06M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| JEFFERIES FINANCIAL GROUP INC. | - | - | - | -68,566 | -100.00% | - | Jun 30, 2024 |
| ALTIUM CAPITAL MANAGEMENT LP | - | - | - | -57,271 | -100.00% | - | Jun 30, 2024 |
| TORNO CAPITAL, LLC | - | - | - | -55,000 | -100.00% | - | Jun 30, 2024 |
| INTRINSIC EDGE CAPITAL MANAGEMENT LLC | - | - | - | -50,000 | -100.00% | - | Jun 30, 2024 |
| EXOME ASSET MANAGEMENT LLC | - | - | - | -45,603 | -100.00% | - | Jun 30, 2024 |
| ALPS ADVISORS INC | - | - | - | -42,419 | -100.00% | - | Jun 30, 2024 |
| GRAHAM CAPITAL MANAGEMENT, L.P. | - | - | - | -26,436 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -26,318 | -100.00% | - | Jun 30, 2024 |
| TWINBEECH CAPITAL LP | - | - | - | -22,714 | -100.00% | - | Jun 30, 2024 |
| CAMPBELL & CO INVESTMENT ADVISER LLC | - | - | - | -16,331 | -100.00% | - | Jun 30, 2024 |
| BAYESIAN CAPITAL MANAGEMENT, LP | - | - | - | -15,355 | -100.00% | - | Jun 30, 2024 |
| TUDOR INVESTMENT CORP ET AL | - | - | - | -13,355 | -100.00% | - | Jun 30, 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC | - | - | - | -10,706 | -100.00% | - | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | - | - | - | -10,462 | -100.00% | - | Jun 30, 2024 |
| E FUND MANAGEMENT CO., LTD. | - | - | - | -10,333 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -10,000 | -100.00% | - | Jun 30, 2024 |
| AQUATIC CAPITAL MANAGEMENT LLC | - | - | - | -8,600 | -100.00% | - | Jun 30, 2024 |
| ALLIANZ ASSET MANAGEMENT GMBH | - | - | - | -7,400 | -100.00% | - | Jun 30, 2024 |
| CAPSTONE INVESTMENT ADVISORS, LLC | - | - | - | -6,738 | -100.00% | - | Jun 30, 2024 |
| AIGEN INVESTMENT MANAGEMENT, LP | - | - | - | -6,479 | -100.00% | - | Jun 30, 2024 |
| QUANTBOT TECHNOLOGIES LP | - | - | - | -3,600 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -2,812 | -100.00% | - | Jun 30, 2024 |
| LAZARD ASSET MANAGEMENT LLC | - | - | - | -1,733 | -100.00% | - | Jun 30, 2024 |
| FERNWOOD INVESTMENT MANAGEMENT, LLC | - | - | - | -1,554 | -100.00% | - | Jun 30, 2024 |
| TRUVESTMENTS CAPITAL LLC | - | - | - | -216 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -10 | -100.00% | - | Jun 30, 2024 |
Rhythm Pharmaceuticals's largest sold out institutional shareholder by shares sold is JEFFERIES FINANCIAL GROUP INC., sold -68.57K shares, valued at -, as of undefined.
Rhythm Pharmaceuticals Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| PRIMECAP Odyssey Funds | 0.94% | 7,705,112 | -214,400 | -2.71% | Jan 31, 2024 |
| HARTFORD HLS SERIES FUND II INC | 0.84% | 207,428 | - | - | Dec 31, 2023 |
| FRANKLIN VALUE INVESTORS TRUST | 0.49% | 1,831,071 | - | - | Jan 31, 2024 |
| CORNERCAP GROUP OF FUNDS /VA/ | 0.30% | 21,403 | - | - | Sep 30, 2022 |
| BlackRock Health Sciences Trust II | 0.22% | 580,575 | 1,857 | 0.32% | Mar 31, 2024 |
| BlackRock Health Sciences Trust | 0.20% | 49,466 | 187 | 0.38% | Mar 31, 2024 |
| MERIDIAN FUND INC | 0.13% | 313,770 | - | - | Mar 28, 2024 |
| Federated Hermes Equity Funds | 0.11% | 2,221,300 | -55,000 | -2.42% | Jan 31, 2024 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.09% | 295,428 | - | - | Mar 31, 2024 |
| Advantage Advisers Xanthus Fund, L.L.C. | 0.08% | 247,501 | - | - | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.08% | 40,461 | - | - | Mar 31, 2024 |
| T. Rowe Price New Horizons Fund, Inc. | 0.07% | 359,878 | - | - | Mar 31, 2024 |
| T. Rowe Price Quantitative Management Funds, Inc. | 0.06% | 199,000 | - | - | Mar 31, 2024 |
| Voya EQUITY TRUST | 0.02% | 34,605 | 34,605 | - | Feb 29, 2024 |
| Voya VARIABLE PRODUCTS TRUST | 0.02% | 8,255 | 8,255 | - | Mar 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND | 0.02% | 70,132 | - | - | Jan 31, 2024 |
| LORD ABBETT SECURITIES TRUST | 0.02% | 72,583 | 72,583 | - | Jan 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 90,702 | -2,184 | -2.35% | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 7,895 | 23 | 0.29% | Mar 31, 2024 |
| VICTORY VARIABLE INSURANCE FUNDS | 0.01% | 6,270 | - | - | Mar 31, 2024 |
| DRIEHAUS MUTUAL FUNDS | 0.01% | 91,556 | 21,846 | 31.34% | Mar 28, 2024 |
| ACAP Strategic Fund | 0.01% | 136,504 | - | - | Mar 31, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.01% | 14,248 | - | - | Mar 31, 2024 |
| Nushares ETF Trust | 0.01% | 56,004 | - | - | Jan 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 20,337 | 310 | 1.55% | Feb 29, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 2,657,926 | -718,068 | -21.27% | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 1,363 | - | - | Mar 31, 2024 |
| Humankind Benefit Corp | 0.01% | 135 | - | - | Dec 31, 2023 |
| ETFis Series Trust I | 0.01% | 7,597 | -9,596 | -55.81% | Jan 31, 2024 |
| FEDERATED HERMES INSURANCE SERIES | 0.00% | 21,000 | -10,335 | -32.98% | Mar 31, 2024 |
| UBS FUNDS | 0.00% | 21,573 | -270 | -1.24% | Mar 31, 2024 |
| JNL VARIABLE FUND LLC | 0.00% | 20,701 | - | - | Mar 31, 2020 |
| ALPS ETF Trust | 0.00% | 43,344 | 3,147 | 7.83% | Feb 29, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 141,363 | -660 | -0.46% | Jan 31, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.00% | 7,261 | - | - | Mar 31, 2024 |
| HARTFORD SERIES FUND INC | 0.00% | 134,803 | - | - | Mar 31, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.00% | 79,172 | - | - | Feb 29, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 72,850 | - | - | Mar 31, 2024 |
| MML SERIES INVESTMENT FUND | 0.00% | 22,026 | - | - | Dec 31, 2023 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 477,353 | 29,786 | 6.66% | Feb 29, 2024 |
| FORUM FUNDS II | 0.00% | 2,260 | - | - | Jan 31, 2024 |
| CLEARWATER INVESTMENT TRUST | 0.00% | 19,482 | 2,101 | 12.09% | Mar 28, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 5,318 | - | - | Mar 31, 2024 |
| Meeder Funds | 0.00% | 6,078 | - | - | Mar 31, 2024 |
| Federated Hermes MDT Series | 0.00% | 3,032 | -25,434 | -89.35% | Jan 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 37,766 | -2,860 | -7.04% | Mar 31, 2024 |
| North Square Investments Trust | 0.00% | 11,610 | 10,450 | 900.86% | Feb 29, 2024 |
| BlackRock ETF Trust | 0.00% | 1,064 | -87 | -7.56% | Jan 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 33,933 | 13,317 | 64.60% | Mar 31, 2024 |
| NORTHWESTERN MUTUAL SERIES FUND INC | 0.00% | 113,662 | - | - | Mar 31, 2024 |
| ProFunds | 0.00% | 11,516 | 4,248 | 58.45% | Mar 31, 2024 |
| Guardian Variable Products Trust | 0.00% | 16,100 | -1,400 | -8.00% | Mar 31, 2024 |
| JANUS INVESTMENT FUND | 0.00% | 291,073 | -208,926 | -41.79% | Dec 31, 2023 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 3,686 | 939 | 34.18% | Mar 31, 2024 |
| HARTFORD MUTUAL FUNDS II INC | 0.00% | 131,528 | - | - | Jan 31, 2024 |
| Brinker Capital Destinations Trust | 0.00% | 47,669 | -7,148 | -13.04% | Feb 29, 2024 |
| Direxion Shares ETF Trust | 0.00% | 116,804 | -10,982 | -8.59% | Jan 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 154,818 | 147 | 0.10% | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 6,982 | 2,033 | 41.08% | Mar 31, 2024 |
| Global X Funds | 0.00% | 23,827 | - | - | Jan 31, 2024 |
| IndexIQ ETF Trust | 0.00% | 1,206 | -420 | -25.83% | Jan 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 277 | - | - | Apr 30, 2021 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 2,548 | 12 | 0.47% | Mar 31, 2024 |
| JPMORGAN INSURANCE TRUST | 0.00% | 6,700 | - | - | Mar 31, 2023 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 41,983 | -126,540 | -75.09% | Jan 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 5,812 | - | - | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 10,678 | 424 | 4.13% | Mar 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 265,469 | 16,977 | 6.83% | Feb 29, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND VI | 0.00% | 2,387 | 2,387 | - | Mar 31, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 8,457 | -23,172 | -73.26% | Mar 31, 2024 |
| FundVantage Trust | 0.00% | 6,535 | -2,763 | -29.72% | Mar 28, 2024 |
| RBB FUND, INC. | 0.00% | 37,270 | 55,120 | -308.80% | Feb 29, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 91,880 | -21,593 | -19.03% | Jan 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 818 | - | - | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 19,247 | 747 | 4.04% | Mar 31, 2024 |
| OLD WESTBURY FUNDS INC | 0.00% | 36,212 | -6,328 | -14.88% | Jan 31, 2024 |
| NORTHERN FUNDS | 0.00% | 38,995 | -1,783 | -4.37% | Mar 28, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 15,603 | -771,300 | -98.02% | Feb 29, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 69,494 | 68,501 | 6898.39% | Feb 29, 2024 |
| THRIVENT SERIES FUND INC | 0.00% | 23,307 | - | - | Mar 28, 2024 |
| Voya INVESTORS TRUST | 0.00% | 10,500 | - | - | Mar 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 3,404 | -21,319 | -86.23% | Mar 31, 2024 |
| NEW COVENANT FUNDS | 0.00% | 687 | - | - | Dec 31, 2023 |
| Victory Portfolios II | 0.00% | 8,110 | 8,110 | - | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 171,058 | -3,472 | -1.99% | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 2,350,662 | -39,988 | -1.67% | Mar 31, 2024 |
| JOHN HANCOCK INVESTMENT TRUST | 0.00% | 11,030 | - | - | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 236,373 | 29,426 | 14.22% | Feb 29, 2024 |
| ARTISAN PARTNERS FUNDS INC | 0.00% | 171,239 | - | - | Mar 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 469 | - | - | Dec 31, 2023 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 14,801 | 6,888 | 87.05% | Mar 31, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 8,354 | 2,985 | 55.60% | Mar 31, 2024 |
| VALIC Co I | 0.00% | 19,716 | -80 | -0.40% | Feb 29, 2024 |
| J.P. Morgan Exchange-Traded Fund Trust | 0.00% | 29,679 | 3,075 | 11.56% | Jan 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 7,013 | - | - | Feb 29, 2024 |
| FLEXSHARES TRUST | 0.00% | 4,700 | - | - | Jan 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 1,700 | - | - | Mar 28, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 232 | - | - | Dec 31, 2023 |
| Brighthouse Funds Trust II | 0.00% | 48,051 | - | - | Mar 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 6,654 | -293 | -4.22% | Jan 31, 2024 |
Rhythm Pharmaceuticals's largest mutual fund holder by % of total assets is "PRIMECAP Odyssey Funds", owning 7.71M shares, compromising 0.94% of its total assets.
Rhythm Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 92 | -47.73% |
| 31 Mar, 24 | 176 | -0.56% |
| 31 Dec, 23 | 177 | 15.69% |
| 30 Sep, 23 | 153 | 27.50% |
| 30 Jun, 23 | 120 | -10.45% |
| 31 Mar, 23 | 134 | 8.94% |
| 31 Dec, 22 | 123 | 8.85% |
| 30 Sep, 22 | 113 | 25.56% |
| 30 Jun, 22 | 90 | -21.74% |
| 31 Mar, 22 | 115 | 19.79% |
| 31 Dec, 21 | 96 | -3.03% |
| 30 Sep, 21 | 99 | -7.48% |
| 30 Jun, 21 | 107 | -17.69% |
| 31 Mar, 21 | 130 | 2.36% |
| 31 Dec, 20 | 127 | 4.10% |
| 30 Sep, 20 | 122 | 34.07% |
| 30 Jun, 20 | 91 | 13.75% |
| 31 Mar, 20 | 80 | -11.11% |
| 31 Dec, 19 | 90 | 4.65% |
| 30 Sep, 19 | 86 | 3.61% |
| 30 Jun, 19 | 83 | -2.35% |
| 31 Mar, 19 | 85 | 16.44% |
| 31 Dec, 18 | 73 | -6.41% |
| 30 Sep, 18 | 78 | -8.24% |
| 30 Jun, 18 | 85 | 57.41% |
| 31 Mar, 18 | 54 | -18.18% |
| 31 Dec, 17 | 66 | - |
As of 30 Jun 24, 92 institutions are holding Rhythm Pharmaceuticals's shares, representing a decrease of -47.73% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 30,896,013 | -54.54% |
| 31 Mar, 24 | 67,967,471 | 1.91% |
| 31 Dec, 23 | 66,693,635 | -2.13% |
| 30 Sep, 23 | 68,148,105 | 2.73% |
| 30 Jun, 23 | 66,334,941 | 9.94% |
| 31 Mar, 23 | 60,336,158 | -3.18% |
| 31 Dec, 22 | 62,315,190 | 4.75% |
| 30 Sep, 22 | 59,492,264 | 29.47% |
| 30 Jun, 22 | 45,949,105 | -5.95% |
| 31 Mar, 22 | 48,854,887 | 0.83% |
| 31 Dec, 21 | 48,453,430 | 0.97% |
| 30 Sep, 21 | 47,985,815 | 1.05% |
| 30 Jun, 21 | 47,485,575 | -0.20% |
| 31 Mar, 21 | 47,582,310 | 17.44% |
| 31 Dec, 20 | 40,516,814 | 3.23% |
| 30 Sep, 20 | 39,247,286 | -4.83% |
| 30 Jun, 20 | 41,237,914 | 1.06% |
| 31 Mar, 20 | 40,806,031 | -3.71% |
| 31 Dec, 19 | 42,379,827 | 23.50% |
| 30 Sep, 19 | 34,316,782 | 9.76% |
| 30 Jun, 19 | 31,264,726 | 1.29% |
| 31 Mar, 19 | 30,865,653 | -2.50% |
| 31 Dec, 18 | 31,656,641 | 1.65% |
| 30 Sep, 18 | 31,142,499 | 0.36% |
| 30 Jun, 18 | 31,030,650 | 27.37% |
| 31 Mar, 18 | 24,362,071 | -0.67% |
| 31 Dec, 17 | 24,526,250 | - |
Rhythm Pharmaceuticals (RYTM) has 30.90M shares outstanding as of 30 Jun 24, down -54.54% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 51.37% | 0.40% |
| 31 Mar, 24 | 113.01% | 0.85% |
| 31 Dec, 23 | 115.64% | 0.83% |
| 30 Sep, 23 | 117.75% | 0.87% |
| 30 Jun, 23 | 116.65% | 1.03% |
| 31 Mar, 23 | 106.40% | 0.74% |
| 31 Dec, 22 | 119.56% | 0.89% |
| 30 Sep, 22 | 115.74% | 1.39% |
| 30 Jun, 22 | 91.17% | 0.96% |
| 31 Mar, 22 | 97.22% | 1.02% |
| 31 Dec, 21 | 97.69% | 1.07% |
| 30 Sep, 21 | 95.50% | 1.07% |
| 30 Jun, 21 | 94.57% | 0.95% |
| 31 Mar, 21 | 99.88% | 1.18% |
| 31 Dec, 20 | 92.03% | 1.16% |
| 30 Sep, 20 | 88.91% | 1.00% |
| 30 Jun, 20 | 94.09% | 1.08% |
| 31 Mar, 20 | 93.16% | 0.92% |
| 31 Dec, 19 | 100.39% | 1.02% |
| 30 Sep, 19 | 99.35% | 1.21% |
| 30 Jun, 19 | 90.75% | 1.13% |
| 31 Mar, 19 | 89.68% | 0.86% |
| 31 Dec, 18 | 102.10% | 1.24% |
| 30 Sep, 18 | 90.91% | 0.74% |
| 30 Jun, 18 | 110.98% | 1.39% |
| 31 Mar, 18 | 89.29% | 1.02% |
| 31 Dec, 17 | 93.70% | - |
As of 30 Jun 24, Rhythm Pharmaceuticals is held by 51.37% institutional shareholders, representing a 0.40% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 48 | -45.45% |
| 31 Mar, 24 | 88 | 2.33% |
| 31 Dec, 23 | 86 | -4.44% |
| 30 Sep, 23 | 90 | 26.76% |
| 30 Jun, 23 | 71 | -5.33% |
| 31 Mar, 23 | 75 | 11.94% |
| 31 Dec, 22 | 67 | -10.67% |
| 30 Sep, 22 | 75 | 78.57% |
| 30 Jun, 22 | 42 | -26.32% |
| 31 Mar, 22 | 57 | 14.00% |
| 31 Dec, 21 | 50 | 35.14% |
| 30 Sep, 21 | 37 | -26.00% |
| 30 Jun, 21 | 50 | -40.48% |
| 31 Mar, 21 | 84 | 47.37% |
| 31 Dec, 20 | 57 | - |
| 30 Sep, 20 | 57 | -3.39% |
| 30 Jun, 20 | 59 | 40.48% |
| 31 Mar, 20 | 42 | -33.33% |
| 31 Dec, 19 | 63 | 46.51% |
| 30 Sep, 19 | 43 | -15.69% |
| 30 Jun, 19 | 51 | 13.33% |
| 31 Mar, 19 | 45 | 9.76% |
| 31 Dec, 18 | 41 | -14.58% |
| 30 Sep, 18 | 48 | -34.25% |
| 30 Jun, 18 | 73 | 204.17% |
| 31 Mar, 18 | 24 | -63.64% |
| 31 Dec, 17 | 66 | - |
48 institutional shareholders have increased their position in RYTM stock as of 30 Jun 24 compared to 88 in the previous quarter (a -45.45% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 30 | -45.45% |
| 31 Mar, 24 | 55 | -15.38% |
| 31 Dec, 23 | 65 | 71.05% |
| 30 Sep, 23 | 38 | 65.22% |
| 30 Jun, 23 | 23 | -8.00% |
| 31 Mar, 23 | 25 | -16.67% |
| 31 Dec, 22 | 30 | 57.89% |
| 30 Sep, 22 | 19 | -36.67% |
| 30 Jun, 22 | 30 | -16.67% |
| 31 Mar, 22 | 36 | 24.14% |
| 31 Dec, 21 | 29 | -17.14% |
| 30 Sep, 21 | 35 | 9.38% |
| 30 Jun, 21 | 32 | 28.00% |
| 31 Mar, 21 | 25 | -35.90% |
| 31 Dec, 20 | 39 | - |
| 30 Sep, 20 | 39 | 116.67% |
| 30 Jun, 20 | 18 | -18.18% |
| 31 Mar, 20 | 22 | 37.50% |
| 31 Dec, 19 | 16 | -38.46% |
| 30 Sep, 19 | 26 | 73.33% |
| 30 Jun, 19 | 15 | -37.50% |
| 31 Mar, 19 | 24 | 14.29% |
| 31 Dec, 18 | 21 | - |
| 30 Sep, 18 | 21 | 133.33% |
| 30 Jun, 18 | 9 | -43.75% |
| 31 Mar, 18 | 16 | - |
| 31 Dec, 17 | - | - |
30 institutional shareholders have reduced their position in RYTM stock as of 30 Jun 24 compared to 55 in the previous quarter (a -45.45% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 92 | -47.73% | 30,896,013 | -54.54% | 51.37% | 0.40% | 48 | -45.45% | 30 | -45.45% |
| 31 Mar, 24 | 176 | -0.56% | 67,967,471 | 1.91% | 113.01% | 0.85% | 88 | 2.33% | 55 | -15.38% |
| 31 Dec, 23 | 177 | 15.69% | 66,693,635 | -2.13% | 115.64% | 0.83% | 86 | -4.44% | 65 | 71.05% |
| 30 Sep, 23 | 153 | 27.50% | 68,148,105 | 2.73% | 117.75% | 0.87% | 90 | 26.76% | 38 | 65.22% |
| 30 Jun, 23 | 120 | -10.45% | 66,334,941 | 9.94% | 116.65% | 1.03% | 71 | -5.33% | 23 | -8.00% |
| 31 Mar, 23 | 134 | 8.94% | 60,336,158 | -3.18% | 106.40% | 0.74% | 75 | 11.94% | 25 | -16.67% |
| 31 Dec, 22 | 123 | 8.85% | 62,315,190 | 4.75% | 119.56% | 0.89% | 67 | -10.67% | 30 | 57.89% |
| 30 Sep, 22 | 113 | 25.56% | 59,492,264 | 29.47% | 115.74% | 1.39% | 75 | 78.57% | 19 | -36.67% |
| 30 Jun, 22 | 90 | -21.74% | 45,949,105 | -5.95% | 91.17% | 0.96% | 42 | -26.32% | 30 | -16.67% |
| 31 Mar, 22 | 115 | 19.79% | 48,854,887 | 0.83% | 97.22% | 1.02% | 57 | 14.00% | 36 | 24.14% |
| 31 Dec, 21 | 96 | -3.03% | 48,453,430 | 0.97% | 97.69% | 1.07% | 50 | 35.14% | 29 | -17.14% |
| 30 Sep, 21 | 99 | -7.48% | 47,985,815 | 1.05% | 95.50% | 1.07% | 37 | -26.00% | 35 | 9.38% |
| 30 Jun, 21 | 107 | -17.69% | 47,485,575 | -0.20% | 94.57% | 0.95% | 50 | -40.48% | 32 | 28.00% |
| 31 Mar, 21 | 130 | 2.36% | 47,582,310 | 17.44% | 99.88% | 1.18% | 84 | 47.37% | 25 | -35.90% |
| 31 Dec, 20 | 127 | 4.10% | 40,516,814 | 3.23% | 92.03% | 1.16% | 57 | - | 39 | - |
| 30 Sep, 20 | 122 | 34.07% | 39,247,286 | -4.83% | 88.91% | 1.00% | 57 | -3.39% | 39 | 116.67% |
| 30 Jun, 20 | 91 | 13.75% | 41,237,914 | 1.06% | 94.09% | 1.08% | 59 | 40.48% | 18 | -18.18% |
| 31 Mar, 20 | 80 | -11.11% | 40,806,031 | -3.71% | 93.16% | 0.92% | 42 | -33.33% | 22 | 37.50% |
| 31 Dec, 19 | 90 | 4.65% | 42,379,827 | 23.50% | 100.39% | 1.02% | 63 | 46.51% | 16 | -38.46% |
| 30 Sep, 19 | 86 | 3.61% | 34,316,782 | 9.76% | 99.35% | 1.21% | 43 | -15.69% | 26 | 73.33% |
| 30 Jun, 19 | 83 | -2.35% | 31,264,726 | 1.29% | 90.75% | 1.13% | 51 | 13.33% | 15 | -37.50% |
| 31 Mar, 19 | 85 | 16.44% | 30,865,653 | -2.50% | 89.68% | 0.86% | 45 | 9.76% | 24 | 14.29% |
| 31 Dec, 18 | 73 | -6.41% | 31,656,641 | 1.65% | 102.10% | 1.24% | 41 | -14.58% | 21 | - |
| 30 Sep, 18 | 78 | -8.24% | 31,142,499 | 0.36% | 90.91% | 0.74% | 48 | -34.25% | 21 | 133.33% |
| 30 Jun, 18 | 85 | 57.41% | 31,030,650 | 27.37% | 110.98% | 1.39% | 73 | 204.17% | 9 | -43.75% |
| 31 Mar, 18 | 54 | -18.18% | 24,362,071 | -0.67% | 89.29% | 1.02% | 24 | -63.64% | 16 | - |
| 31 Dec, 17 | 66 | - | 24,526,250 | - | 93.70% | - | 66 | - | - | - |
Rhythm Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Rhythm Pharmaceuticals's stock was made by TETRAULT LYNN A. on Aug 14 2024, selling 10,000 shares at $4.15 per share (valued at $41.50K).
Rhythm Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 7 | 12 | 58.33% |
| Q2 2024 | 24 | 14 | 171.43% |
| Q1 2024 | 33 | 45 | 73.33% |
| Q4 2023 | 12 | 25 | 48.00% |
| Q3 2023 | 4 | 10 | 40.00% |
| Q2 2023 | 16 | 2 | 800.00% |
| Q1 2023 | 23 | 28 | 82.14% |
| Q4 2022 | - | 1 | - |
| Q3 2022 | 1 | 3 | 33.33% |
| Q2 2022 | 14 | 2 | 700.00% |
| Q1 2022 | 20 | 12 | 166.67% |
| Q3 2021 | 4 | - | - |
| Q2 2021 | 9 | 1 | 900.00% |
| Q1 2021 | 15 | 2 | 750.00% |
| Q4 2020 | 4 | 6 | 66.67% |
| Q3 2020 | 4 | 5 | 80.00% |
| Q2 2020 | 11 | 28 | 39.29% |
| Q1 2020 | 10 | 12 | 83.33% |
| Q4 2019 | 1 | 18 | 5.56% |
| Q3 2019 | 4 | 3 | 133.33% |
7 total buy trades, and 12 total sell trades (buy/sell ratio of 0.58%) were made by Rhythm Pharmaceuticals's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 7 | - |
| Q2 2024 | - | 3 | - |
| Q1 2024 | - | 29 | - |
| Q4 2023 | - | 13 | - |
| Q3 2023 | - | 4 | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | 17 | - |
| Q4 2022 | - | - | - |
| Q3 2022 | - | 2 | - |
| Q2 2022 | - | 1 | - |
| Q1 2022 | - | 5 | - |
| Q3 2021 | - | - | - |
| Q2 2021 | - | - | - |
| Q1 2021 | 1 | 1 | 100.00% |
| Q4 2020 | - | 6 | - |
| Q3 2020 | - | 3 | - |
| Q2 2020 | - | 28 | - |
| Q1 2020 | - | 6 | - |
| Q4 2019 | - | 17 | - |
| Q3 2019 | - | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 7 open market sell trades of Rhythm Pharmaceuticals's stocks.
Rhythm Pharmaceuticals Peer Ownership
| Ticker | Company |
|---|---|
| PLRX | Pliant Therapeutics, Inc. |
| NUVL | Nuvalent, Inc. |
| AKRO | Akero Therapeutics, Inc. |
| ARVN | Arvinas, Inc. |
| CGEM | Cullinan Oncology, Inc. |
| RVMD | Revolution Medicines, Inc. Warrant |
| KNSA | Kiniksa Pharmaceuticals, Ltd. |
| VRDN | Viridian Therapeutics, Inc. |
| MGTX | MeiraGTx Holdings plc |
| STOK | Stoke Therapeutics, Inc. |
| RCKT | Rocket Pharmaceuticals, Inc. |
| VTYX | Ventyx Biosciences, Inc. |
| RNA | Avidity Biosciences, Inc. |
| BDTX | Black Diamond Therapeutics, Inc. |
| RLAY | Relay Therapeutics, Inc. |
| SNDX | Syndax Pharmaceuticals, Inc. |
| INZY | Inozyme Pharma, Inc. |
| ACLX | Arcellx, Inc. |
| SLDB | Solid Biosciences Inc. |
| PTGX | Protagonist Therapeutics, Inc. |
| QURE | uniQure N.V. |
RYTM Ownership FAQ
Who Owns Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals is owned by institutional shareholders (51.37%), insiders (0.57%), and public (48.06%). The largest institutional shareholder of Rhythm Pharmaceuticals is PRIMECAP MANAGEMENT CO/CA/ (12.16% of total shares) and the top mutual fund owner is PRIMECAP Odyssey Funds (0.94% of total shares).
Who are the major institutional shareholders of Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals's major institutional shareholders are PRIMECAP MANAGEMENT CO/CA/, BLACKROCK INC., BAKER BROS. ADVISORS LP, RA CAPITAL MANAGEMENT, L.P., and GOLDMAN SACHS GROUP INC. The top five shareholders own together 52.92% of the company's share outstanding.
How many Rhythm Pharmaceuticals shareholders are there?
As of Jun 2024, there are 92 institutional shareholders of Rhythm Pharmaceuticals.
What percentage of Rhythm Pharmaceuticals is owned by PRIMECAP MANAGEMENT CO/CA/?
PRIMECAP MANAGEMENT CO/CA/ owns 7.31M shares of Rhythm Pharmaceuticals, representing 12.16% of the company's total shares outstanding, valued at $300.25M (as of Jun 2024).
What percentage of Rhythm Pharmaceuticals is owned by BLACKROCK INC?
As of Jun 2024, BLACKROCK INC holds 6.74M shares of Rhythm Pharmaceuticals (RYTM), compromising 11.21% of the company, valued at $276.82M.
What percentage of Rhythm Pharmaceuticals is owned by BAKER BROS. ADVISORS LP?
BAKER BROS. ADVISORS LP is the third largest holder of Rhythm Pharmaceuticals. The company owns 6.4M of the company's shares outstanding (worth $262.72M).